GON has been designated a 2025 Shandong Provincial "One Enterprise, One Technology" R&D Center, confirming its innovation capabilities in new materials. The company maintains a full-chain R&D system covering "monomers–resins–modified materials–finished products," with 488 patents and participation in multiple industry standards.
Through its "One Core, Two Wings" strategy, GON has advanced polymer modification technology, achieving batch supply of PEEK specialty plastics and PHB biodegradable materials. In healthcare, it expands pharmaceutical and health applications of gelatin and collagen via "collagen+" technology.
This approval demonstrates GON's mature innovation system. The company will continue to increase R&D investment and strengthen core technology control, supporting Shandong's new materials industry development.
